Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 36

    1.

    Effect of dipyridamole plus aspirin on hemodialysis graft patency.

    Dixon BS, Beck GJ, Vazquez MA, Greenberg A, Delmez JA, Allon M, Dember LM, Himmelfarb J, Gassman JJ, Greene T, Radeva MK, Davidson IJ, Ikizler TA, Braden GL, Fenves AZ, Kaufman JS, Cotton JR Jr, Martin KJ, McNeil JW, Rahman A, Lawson JH, Whiting JF, Hu B, Meyers CM, Kusek JW, Feldman HI; DAC Study Group.

    N Engl J Med. 2009 May 21;360(21):2191-201.PMID: 19458364 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Modern treatment of amyloidosis: unresolved questions.

    Dember LM.

    J Am Soc Nephrol. 2009 Mar;20(3):469-72. Epub 2008 Dec 10. Review.PMID: 19073820 [PubMed - indexed for MEDLINE]Related articles

    3.

    Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial.

    Dember LM, Beck GJ, Allon M, Delmez JA, Dixon BS, Greenberg A, Himmelfarb J, Vazquez MA, Gassman JJ, Greene T, Radeva MK, Braden GL, Ikizler TA, Rocco MV, Davidson IJ, Kaufman JS, Meyers CM, Kusek JW, Feldman HI; Dialysis Access Consortium Study Group.

    JAMA. 2008 May 14;299(18):2164-71.PMID: 18477783 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Early fistula failure: back to basics.

    Dember LM, Dixon BS.

    Am J Kidney Dis. 2007 Nov;50(5):696-9. No abstract available. PMID: 17954281 [PubMed - indexed for MEDLINE]Related articles

    5.

    Light chains, casts, sheets and fibrils: monoclonal immunoglobulin diseases and immunotactoid/fibrillary glomerulopathy.

    Dember LM.

    Clin J Am Soc Nephrol. 2006 Nov;1(6):1320-1. Epub 2006 Oct 11. No abstract available. PMID: 17699364 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Tandem cycles of high-dose melphalan and autologous stem cell transplantation increases the response rate in AL amyloidosis.

    Sanchorawala V, Wright DG, Quillen K, Finn KT, Dember LM, Berk JL, Doros G, Fisher C, Skinner M, Seldin DC.

    Bone Marrow Transplant. 2007 Sep;40(6):557-62. Epub 2007 Jun 25. Erratum in: Bone Marrow Transplant. 2007 Sep;40(6):607. PMID: 17589534 [PubMed - indexed for MEDLINE]Related articles

    7.

    Eprodisate for the treatment of renal disease in AA amyloidosis.

    Dember LM, Hawkins PN, Hazenberg BP, Gorevic PD, Merlini G, Butrimiene I, Livneh A, Lesnyak O, Puéchal X, Lachmann HJ, Obici L, Balshaw R, Garceau D, Hauck W, Skinner M; Eprodisate for AA Amyloidosis Trial Group.

    N Engl J Med. 2007 Jun 7;356(23):2349-60.PMID: 17554116 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Anemia in patients with chronic kidney disease: defining the optimal hemoglobin target.

    Dember LM.

    Nat Clin Pract Nephrol. 2007 May;3(5):244-5. Epub 2007 Apr 3. No abstract available. PMID: 17406381 [PubMed]Related articles

    9.

    Amyloidosis-associated kidney disease.

    Dember LM.

    J Am Soc Nephrol. 2006 Dec;17(12):3458-71. Epub 2006 Nov 8. Review.PMID: 17093068 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Clinical and molecular characteristics of patients with non-amyloid light chain deposition disorders, and outcome following treatment with high-dose melphalan and autologous stem cell transplantation.

    Weichman K, Dember LM, Prokaeva T, Wright DG, Quillen K, Rosenzweig M, Skinner M, Seldin DC, Sanchorawala V.

    Bone Marrow Transplant. 2006 Sep;38(5):339-43. Epub 2006 Jul 24.PMID: 16862166 [PubMed - indexed for MEDLINE]Related articles

    11.

    Dialysis-related amyloidosis: late finding or hidden epidemic?

    Dember LM, Jaber BL.

    Semin Dial. 2006 Mar-Apr;19(2):105-9. Review.PMID: 16551286 [PubMed - indexed for MEDLINE]Related articles

    12.

    Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis.

    Akar H, Seldin DC, Magnani B, O'Hara C, Berk JL, Schoonmaker C, Cabral H, Dember LM, Sanchorawala V, Connors LH, Falk RH, Skinner M.

    Amyloid. 2005 Dec;12(4):210-5.PMID: 16399645 [PubMed - indexed for MEDLINE]Related articles

    13.

    Design of the Dialysis Access Consortium (DAC) Clopidogrel Prevention of Early AV Fistula Thrombosis Trial.

    Dember LM, Kaufman JS, Beck GJ, Dixon BS, Gassman JJ, Greene T, Himmelfarb J, Hunsicker LG, Kusek JW, Lawson JH, Middleton JP, Radeva M, Schwab SJ, Whiting JF, Feldman HI; DAC Study Group.

    Clin Trials. 2005;2(5):413-22.PMID: 16317810 [PubMed - indexed for MEDLINE]Related articles

    14.

    Design of the Dialysis Access Consortium (DAC) Aggrenox Prevention Of Access Stenosis Trial.

    Dixon BS, Beck GJ, Dember LM, Depner TA, Gassman JJ, Greene T, Himmelfarb J, Hunsicker LG, Kaufman JS, Lawson JH, Meyers CM, Middleton JP, Radeva M, Schwab SJ, Whiting JF, Feldman HI; DAC Study Group.

    Clin Trials. 2005;2(5):400-12.PMID: 16317809 [PubMed - indexed for MEDLINE]Related articles

    15.

    Emerging treatment approaches for the systemic amyloidoses.

    Dember LM.

    Kidney Int. 2005 Sep;68(3):1377-90. No abstract available. PMID: 16105087 [PubMed - indexed for MEDLINE]Related articles

    16.

    Case records of the Massachusetts General Hospital. Case 15-2005. An 80-year-old man with shortness of breath, edema, and proteinuria.

    Dember LM, Shepard JA, Nesta F, Stone JR.

    N Engl J Med. 2005 May 19;352(20):2111-9. No abstract available. PMID: 15901865 [PubMed - indexed for MEDLINE]Related articles

    17.

    Stress granule assembly is mediated by prion-like aggregation of TIA-1.

    Gilks N, Kedersha N, Ayodele M, Shen L, Stoecklin G, Dember LM, Anderson P.

    Mol Biol Cell. 2004 Dec;15(12):5383-98. Epub 2004 Sep 15.PMID: 15371533 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Randomized controlled trial of prophylactic repair of hemodialysis arteriovenous graft stenosis.

    Dember LM, Holmberg EF, Kaufman JS.

    Kidney Int. 2004 Jul;66(1):390-8.PMID: 15200448 [PubMed - indexed for MEDLINE]Related articles

    19.

    Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation.

    Seldin DC, Anderson JJ, Sanchorawala V, Malek K, Wright DG, Quillen K, Finn KT, Berk JL, Dember LM, Falk RH, Skinner M.

    Blood. 2004 Sep 15;104(6):1888-93. Epub 2004 May 20.PMID: 15155460 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study.

    Skinner M, Sanchorawala V, Seldin DC, Dember LM, Falk RH, Berk JL, Anderson JJ, O'Hara C, Finn KT, Libbey CA, Wiesman J, Quillen K, Swan N, Wright DG.

    Ann Intern Med. 2004 Jan 20;140(2):85-93.PMID: 14734330 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial.

    Sanchorawala V, Wright DG, Seldin DC, Falk RH, Finn KT, Dember LM, Berk JL, Quillen K, Anderson JJ, Comenzo RL, Skinner M.

    Bone Marrow Transplant. 2004 Feb;33(4):381-8.PMID: 14676787 [PubMed - indexed for MEDLINE]Related articles

    22.

    Persistent pleural effusions in primary systemic amyloidosis: etiology and prognosis.

    Berk JL, Keane J, Seldin DC, Sanchorawala V, Koyama J, Dember LM, Falk RH.

    Chest. 2003 Sep;124(3):969-77.PMID: 12970025 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Thrombosis in end-stage renal disease.

    Casserly LF, Dember LM.

    Semin Dial. 2003 May-Jun;16(3):245-56. Review.PMID: 12753687 [PubMed - indexed for MEDLINE]Related articles

    24.

    Incidence and outcome of acute renal failure complicating autologous stem cell transplantation for AL amyloidosis.

    Fadia A, Casserly LF, Sanchorawala V, Seldin DC, Wright DG, Skinner M, Dember LM.

    Kidney Int. 2003 May;63(5):1868-73.PMID: 12675865 [PubMed - indexed for MEDLINE]Related articles

    25.

    Tolerability and efficacy of thalidomide for the treatment of patients with light chain-associated (AL) amyloidosis.

    Seldin DC, Choufani EB, Dember LM, Wiesman JF, Berk JL, Falk RH, O'Hara C, Fennessey S, Finn KT, Wright DG, Skinner M, Sanchorawala V.

    Clin Lymphoma. 2003 Mar;3(4):241-6.PMID: 12672274 [PubMed - indexed for MEDLINE]Related articles

    26.

    High-dose intravenous melphalan with autologous stem cell transplantation in AL amyloidosis-associated end-stage renal disease.

    Casserly LF, Fadia A, Sanchorawala V, Seldin DC, Wright DG, Skinner M, Dember LM.

    Kidney Int. 2003 Mar;63(3):1051-7.PMID: 12631087 [PubMed - indexed for MEDLINE]Related articles

    27.

    Low-dose continuous oral melphalan for the treatment of primary systemic (AL) amyloidosis.

    Sanchorawala V, Wright DG, Seldin DC, Falk RH, Berk JL, Dember LM, Finn KT, Skinner M.

    Br J Haematol. 2002 Jun;117(4):886-9.PMID: 12060126 [PubMed - indexed for MEDLINE]Related articles

    28.

    Critical care issues in the patient with chronic renal failure.

    Dember LM.

    Crit Care Clin. 2002 Apr;18(2):421-40. Review.PMID: 12053841 [PubMed - indexed for MEDLINE]Related articles

    29.

    Value of static venous pressure for predicting arteriovenous graft thrombosis.

    Dember LM, Holmberg EF, Kaufman JS.

    Kidney Int. 2002 May;61(5):1899-904.PMID: 11967043 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.

    Sanchorawala V, Wright DG, Seldin DC, Dember LM, Finn K, Falk RH, Berk J, Quillen K, Skinner M.

    Bone Marrow Transplant. 2001 Oct;28(7):637-42. Review.PMID: 11704785 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    MRI isolation of infected renal cyst in autosomal dominant polycystic kidney disease.

    Chicoskie C, Chaoui A, Kuligowska E, Dember LM, Tello R.

    Clin Imaging. 2001 Mar-Apr;25(2):114-7.PMID: 11483421 [PubMed - indexed for MEDLINE]Related articles

    32.

    Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on al amyloidosis-associated renal disease.

    Dember LM, Sanchorawala V, Seldin DC, Wright DG, LaValley M, Berk JL, Falk RH, Skinner M.

    Ann Intern Med. 2001 May 1;134(9 Pt 1):746-53.PMID: 11329232 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Venous thromboembolism in end-stage renal disease.

    Casserly LF, Reddy SM, Dember LM.

    Am J Kidney Dis. 2000 Aug;36(2):405-11.PMID: 10922321 [PubMed - indexed for MEDLINE]Related articles

    34.

    Intermediate-dose intravenous melphalan and blood stem cells mobilized with sequential GM+G-CSF or G-CSF alone to treat AL (amyloid light chain) amyloidosis.

    Comenzo RL, Sanchorawala V, Fisher C, Akpek G, Farhat M, Cerda S, Berk JL, Dember LM, Falk R, Finn K, Skinner M, Vosburgh E.

    Br J Haematol. 1999 Mar;104(3):553-9.PMID: 10086794 [PubMed - indexed for MEDLINE]Related articles

    35.

    Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients.

    Comenzo RL, Vosburgh E, Falk RH, Sanchorawala V, Reisinger J, Dubrey S, Dember LM, Berk JL, Akpek G, LaValley M, O'hara C, Arkin CF, Wright DG, Skinner M.

    Blood. 1998 May 15;91(10):3662-70.PMID: 9573002 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Individual RNA recognition motifs of TIA-1 and TIAR have different RNA binding specificities.

    Dember LM, Kim ND, Liu KQ, Anderson P.

    J Biol Chem. 1996 Feb 2;271(5):2783-8.PMID: 8576255 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...

    Recent activity

    Your browsing activity is temporarily unavailable.

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...